MARKET

CRMD

CRMD

Cormedix
NASDAQ
7.87
+0.02
+0.19%
Opening 14:58 09/28 EDT
OPEN
7.85
PREV CLOSE
7.85
HIGH
7.89
LOW
7.77
VOLUME
240.87K
TURNOVER
--
52 WEEK HIGH
13.02
52 WEEK LOW
6.13
MARKET CAP
613.03M
P/E (TTM)
3.692
1D
5D
1M
3M
1Y
5Y
1D
Oppenheimer Initiates Coverage of CorMedix at Outperform
NASDAQ · 5d ago
CorMedix Price Target Announced at $15.00/Share by Oppenheimer
Dow Jones · 5d ago
Oppenheimer Initiates Coverage On Cormedix with Outperform Rating, Announces Price Target of $15
Benzinga · 5d ago
Weekly Report: what happened at CRMD last week (0914-0918)?
Weekly Report · 09/21 09:28
Weekly Report: what happened at CRMD last week (0907-0911)?
Weekly Report · 09/14 09:30
Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet
NASDAQ · 09/07 13:55
Weekly Report: what happened at CRMD last week (0831-0904)?
Weekly Report · 09/07 09:28
CorMedix (CRMD) Upgraded to Buy: Here's Why
NASDAQ · 08/31 16:00
More
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.